MRNA
Moderna, Inc. · Healthcare · Biotechnology
TECHBuyZACKSHold
R500#197 today
$190.01
+0.57% today · -4.46% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- MRNA +0.57% on the last session vs SPY +0.74%: −0.2 pts of stock-specific move.
- Aftermath, big drop (Sep 30): After its 59 big drops in the past 5 years, MRNA typically lost 3.5% over the next week (median) and was higher only 36% of the time; half the outcomes fell between -8.2% and +7.4%. An ordinary week: -0.3%. Among S&P 500 stocks after big drops, that ranks #466 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Key facts
- Market cap
- $75.9B
- Held by institutions
- 80.5%
- Short interest
- 10.1%
- 52-week range
- 22.28–208.90
- Analyst mean target
- —
- Next earnings
- Nov 5 BMO
- Forward P/E
- -42.7
Recent events
Earnings ▲
2Q2026 results: EPS −$1.97 vs −$2.06 expected beat +$0.09 (+4.3%); revenue $145.0M; next session -5.3% (-6.1 vs SPY)Earnings ▲
1Q2026 results: EPS −$3.40 vs −$3.88 expected beat +$0.48 (+12.4%); revenue $389.0M; next session -1.2% (-1.5 vs SPY)Earnings ▲
4Q2025 results: EPS −$2.11 vs −$2.60 expected beat +$0.49 (+18.9%); revenue $678.0M; next session +5.3% (+5.2 vs SPY)Earnings ▲
3Q2025 results: EPS −$0.51 vs −$2.18 expected beat +$1.67 (+76.6%); revenue $1.0B; next session +3.3% (+4.3 vs SPY)